BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simone CB 2nd, Plastaras JP, Jabbour SK, Lee A, Lee NY, Choi JI, Frank SJ, Chang JY, Bradley J. Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies. Semin Radiat Oncol 2020;30:253-61. [PMID: 32503791 DOI: 10.1016/j.semradonc.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Doi H, Tamari K, Oh RJ, Nieder C. New clinical data on human spinal cord re-irradiation tolerance. Strahlenther Onkol 2021;197:463-73. [PMID: 33950265 DOI: 10.1007/s00066-021-01772-7] [Reference Citation Analysis]
2 Press RH, Bakst RL, Sharma S, Kabarriti R, Garg MK, Yeh B, Gelbum DY, Hasan S, Choi JI, Barker CA, Chhabra AM, Simone CB 2nd, Lee NY. Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers. Int J Part Ther 2021;8:248-60. [PMID: 34285951 DOI: 10.14338/IJPT-D-20-00055.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ronchi S, Mastella E, Vischioni B, Bonora M, Orlandi E. Therapeutic challenges in radiation-induced salivary gland cancers. Curr Opin Otolaryngol Head Neck Surg 2021;29:120-5. [PMID: 33394737 DOI: 10.1097/MOO.0000000000000694] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol 2021;165:142-51. [PMID: 34688807 DOI: 10.1016/j.radonc.2021.10.010] [Reference Citation Analysis]
5 Beddok A, Calugaru V, de Marzi L, Graff P, Dumas JL, Goudjil F, Dendale R, Minsat M, Verrelle P, Buvat I, Créhange G. Clinical and technical challenges of cancer reirradiation: Words of wisdom. Crit Rev Oncol Hematol 2022;:103655. [PMID: 35398521 DOI: 10.1016/j.critrevonc.2022.103655] [Reference Citation Analysis]